BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28166196)

  • 1. The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia.
    Wakim J; Arman E; Becker-Herman S; Kramer MP; Bakos E; Shachar I; Elson A
    Oncogene; 2017 Jun; 36(26):3686-3694. PubMed ID: 28166196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.
    Motiwala T; Kutay H; Zanesi N; Frissora FW; Mo X; Muthusamy N; Jacob ST
    Leukemia; 2015 Jun; 29(6):1350-9. PubMed ID: 25482129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia.
    Motiwala T; Zanesi N; Datta J; Roy S; Kutay H; Checovich AM; Kaou M; Zhong Y; Johnson AJ; Lucas DM; Heerema NA; Hagan J; Mo X; Jarjoura D; Byrd JC; Croce CM; Jacob ST
    Blood; 2011 Dec; 118(23):6132-40. PubMed ID: 22001392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyn kinase and ZAP70 are substrates of PTPROt in B-cells: Lyn inactivation by PTPROt sensitizes leukemia cells to VEGF-R inhibitor pazopanib.
    Motiwala T; Datta J; Kutay H; Roy S; Jacob ST
    J Cell Biochem; 2010 Jul; 110(4):846-56. PubMed ID: 20564182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the phosphatase PTPROt at Tyr
    Roth L; Wakim J; Wasserman E; Shalev M; Arman E; Stein M; Brumfeld V; Sagum CA; Bedford MT; Tuckermann J; Elson A
    Sci Signal; 2019 Jan; 12(563):. PubMed ID: 30622194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
    Motiwala T; Majumder S; Kutay H; Smith DS; Neuberg DS; Lucas DM; Byrd JC; Grever M; Jacob ST
    Clin Cancer Res; 2007 Jun; 13(11):3174-81. PubMed ID: 17545520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia.
    Nguyen PH; Fedorchenko O; Rosen N; Koch M; Barthel R; Winarski T; Florin A; Wunderlich FT; Reinart N; Hallek M
    Cancer Cell; 2016 Oct; 30(4):610-622. PubMed ID: 27728807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.
    Juszczynski P; Chen L; O'Donnell E; Polo JM; Ranuncolo SM; Dalla-Favera R; Melnick A; Shipp MA
    Blood; 2009 Dec; 114(26):5315-21. PubMed ID: 19855081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.
    McKenna MK; Noothi SK; Alhakeem SS; Oben KZ; Greene JT; Mani R; Perry KL; Collard JP; Rivas JR; Hildebrandt GC; Fleischman RA; Durbin EB; Byrd JC; Wang C; Muthusamy N; Rangnekar VM; Bondada S
    Blood; 2018 Jun; 131(26):2943-2954. PubMed ID: 29695515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival.
    Pal Singh S; de Bruijn MJW; Velaso Gago da Graça C; Corneth OBJ; Rip J; Stadhouders R; Meijers RWJ; Schurmans S; Kerr WG; Ter Burg J; Eldering E; Langerak AW; Pillai SY; Hendriks RW
    J Immunol; 2020 Jan; 204(2):360-374. PubMed ID: 31836657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells.
    Jablonska E; Gorniak P; Szydlowski M; Sewastianik T; Bialopiotrowicz E; Polak A; Warzocha K; Juszczynski P
    Exp Hematol; 2017 Feb; 46():56-61.e1. PubMed ID: 27720936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells.
    Talab F; Allen JC; Thompson V; Lin K; Slupsky JR
    Mol Cancer Res; 2013 May; 11(5):541-54. PubMed ID: 23505068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
    Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
    Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia.
    Schmid VK; Khadour A; Ahmed N; Brandl C; Nitschke L; Rajewsky K; Jumaa H; Hobeika E
    Haematologica; 2022 Aug; 107(8):1796-1814. PubMed ID: 35021605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
    Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
    Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells.
    Suljagic M; Laurenti L; Tarnani M; Alam M; Malek SN; Efremov DG
    Leukemia; 2010 Dec; 24(12):2063-71. PubMed ID: 20861921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
    Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia.
    Shukla V; Shukla A; Joshi SS; Lu R
    Oncotarget; 2016 Jul; 7(27):41081-41094. PubMed ID: 27232759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of B cell receptor signaling in IL-10 production by normal and malignant B-1 cells.
    Alhakeem SS; Sindhava VJ; McKenna MK; Gachuki BW; Byrd JC; Muthusamy N; Bondada S
    Ann N Y Acad Sci; 2015 Dec; 1362(1):239-249. PubMed ID: 26096907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPROt maintains T cell immunity in the microenvironment of hepatocellular carcinoma.
    Hou J; Deng L; Zhuo H; Lin Z; Chen Y; Jiang R; Chen D; Zhang X; Huang X; Sun B
    J Mol Cell Biol; 2015 Aug; 7(4):338-50. PubMed ID: 26117839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.